IP Library Granted Patent US 12,568,969
Granted Patent B2
US 12,568,969 · App. 17/796,542 · Granted Mar 10, 2026

Pyridine compounds for controlling invertebrate pests

Inventors: Omar Khaled Ahmad (Cambridge, MA); Twyla A. Briddell (Elkton, MD); Dominic Ming-Tak Chan (Wilmington, DE); Yuzhong Chen (Wilmington, DE); Jason Charles Hamm (Middletown, DE); Moumita Kar (Hyderabad, IN); Thomas Francis Pahutski, Jr. (Elkton, MD); Thomas Martin Stevenson (Newark, DE); Ming Xu (Newark, DE); Rachel Slack (Bel Air, MD)
Assignee: FMC Corporation
A01N43/647A01N25/04A01N25/08A01N25/12A01N25/14A01N25/34A01N43/40A01N43/50A01N43/56A01N43/653A01N43/713A01N43/76A01N43/78A01N43/80A01N43/82A01N51/00A01P7/04C07D401/04C07D401/14C07D405/04C07D405/14C07D409/04C07D413/04C07D417/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,568,969
App. No.
17/796,542
Granted
Mar 10, 2026
Kind
B2
Abstract

Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, Wherein R 1 , A, R 2 , R 4 , R 5 and Q are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the disclosure.

Claims (41)

1 . A compound selected from Formula 1, an N-oxides or salt thereof,

wherein

R 1 is F;

A is N or CR 3 ;

R 2 is H, halogen, CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 3 -C 4 cycloalkyl, C 3 -C 4 halocycloalkyl, C 1 -C 4 alkoxy or C 1 -C 4 haloalkoxy;

R 3 is H, halogen, CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 3 -C 4 cycloalkyl, C 3 -C 4 halocycloalkyl, C 1 -C 4 alkoxy or C 1 -C 4 haloalkoxy;

R 4 is selected from U-31 to U-35 and U-44 to U-48

each R v is independently H, cyano, halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 2 -C 6 cyanoalkyl, C 1 -C 6 hydroxyalkyl, C 4 -C 10 alkylcycloalkyl, C 4 -C 10 cycloalkylalkyl, C 3 -C 6 cycloalkenyl, C 3 -C 6 halocycloalkenyl, C 2 -C 6 alkoxyalkyl, C 4 -C 10 cycloalkoxyalkyl, C 3 -C 10 alkoxyalkoxyalkyl, C 2 -C 6 alkylthioalkyl, C 2 -C 6 alkylsulfinylalkyl, C 3 -C 6 cycloalkoxy, C 3 -C 6 halocycloalkoxy, C 4 -C 10 cycloalkylalkoxy, C 2 -C 6 alkenyloxy, C 2 -C 6 haloalkenyloxy, C 2 -C 6 alkoxyalkoxy, C 2 -C 6 alkylcarbonyloxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 3 -C 6 cycloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 3 -C 6 cycloalkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 6 dialkylamino, C 1 -C 6 haloalkylamino, C 2 -C 6 halodialkylamino or C 3 -C 6 cycloalkylamino;

r is 1, 2, 3, 4 or 5;

R 5 is H, halogen, CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 3 -C 4 cycloalkyl, C 3 -C 4 halocycloalkyl, C 1 -C 4 alkoxy or C 1 -C 4 haloalkoxy;

Q is a six membered aromatic ring containing ring members selected from carbon atoms and up to 2 nitrogen atoms,

R w is independently H, cyano, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 2 -C 6 cyanoalkyl, C 1 -C 6 hydroxyalkyl, C 4 -C 10 alkylcycloalkyl, C 4 -C 10 cycloalkylalkyl, C 3 -C 6 cycloalkenyl, C 3 -C 6 halocycloalkenyl, C 2 -C 6 alkoxyalkyl, C 4 -C 10 cycloalkoxyalkyl, C 3 -C 10 alkoxyalkoxyalkyl, C 2 -C 6 alkylthioalkyl, C 2 -C 6 alkylsulfinylalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 3 -C 6 cycloalkoxy, C 3 -C 6 halocycloalkoxy, C 4 -C 10 cycloalkylalkoxy, C 2 -C 6 alkenyloxy, C 2 -C 6 haloalkenyloxy, C 2 -C 6 alkoxyalkoxy, C 2 -C 6 alkylcarbonyloxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 3 -C 6 cycloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 3 -C 6 cycloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 3 -C 6 cycloalkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 6 dialkylamino, C 1 -C 6 haloalkylamino, C 2 -C 6 halodialkylamino or C 3 -C 6 cycloalkylamino; or two R w on adjacent carbon atoms together can form a —OCF2O—, —OCH2O—, —OCF2S—, —OCH2CH2)-, OCF2CF2O— cyclic ether ring;

s is 1, 2, 3, 4 or 5;

n is 0, 1 or 2.

2 . The compound of claim 1 wherein:

A is CR 3 .

3 . The compound of claim 2 wherein:

R 2 is H, or halogen.

4 . The compound of claim 3 wherein:

R 2 is H;

R 3 is H or halogen.

5 . The compound of claim 1 wherein the compound is selected from the group consisting of:

3-Fluoro-4-[fluoro[4-(trifluoromethoxy)phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Chloro-4-[fluoro[4-(trifluoromethoxy)phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Fluoro-4-[fluoro[4-[(trifluoromethyl)thio]phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Chloro-4-[fluoro[4-[(trifluoromethyl)thio]phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Fluoro-4-[fluoro[4-(trifluoromethyl)phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Fluoro-4-[fluoro[4-[(trifluoromethyl)sulfinyl]phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Bromo-4-[fluoro[4-[(trifluoromethyl)thio]phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine.

6 . The compound of claim 5 wherein the compound is selected from the group consisting of:

3-Fluoro-4-[fluoro[4-(trifluoromethoxy)phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Chloro-4-[fluoro[4-(trifluoromethoxy)phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Chloro-4-[fluoro[4-[(trifluoromethyl)thio]phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Fluoro-4-[fluoro[4-[(trifluoromethyl)thio]phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine;

3-Bromo-4-[fluoro[4-[(trifluoromethyl)thio]phenyl]methyl]-5-(2H-1,2,3-triazol-2-yl)pyridine.

7 . A composition comprising a compound of claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent.

8 . The composition of claim 7 wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, afidopyropen, amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, benfuracarb, bensultap, bifenthrin, bifenazate, bistrifluron, borate, bromantraniliprole, buprofezin, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clofentezin, clothianidin, cyantraniliprole, cyclaniliprole, cycloprothrin, cycloxaprid, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalodiamide, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dichlorantraniliprole, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenitrothion, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flometoquin, flonicamid, flubendiamide, flucythrinate, flufenerim, flufenoxuron, flufenoxystrobin, fluensulfone, fluopyram, flupyradifurone, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, heptafluthrin, hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufenuron, malathion, meperfluthrin, metaflumizone, metaldehyde, methamidophos, methidathion, methiocarb, methomyl, methoprene, methoxychlor, methoxyfenozide, metofluthrin, monocrotophos, monofluorothrin, nicotine, N-[1,1-dimethyl-2-(methylthio)ethyl]-7-fluoro-2-(3-pyridinyl)-2H-indazole-4-carboxamide, N-[1,1-dimethyl-2-(methylsulfinyl)ethyl]-7-fluoro-2-(3-pyridinyl)-2H-indazole-4-carboxamide, N-[1,1-dimethyl-2-(methylsulfonyl)ethyl]-7-fluoro-2-(3-pyridinyl)-2H-indazole-4-carboxamide, N-(1-netliylcyclopropyl)-2-(3-pyridinyl)-2H-indazole-4-carboxanide, N-[1-(difluoromethyl)cyclopropyl]-2-(3-pyridinyl)-2H-indazole-4-carboxamide, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pyflubumide, pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriminostrobin, pyriprole, pyriproxyfen, rotenone, ryanodine, silafluofen, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulprofos, sulfoxaflor, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, tetrachlorantraniliprole, tetrachlorvinphos, tetramethrin, tetramethylfluthrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tioxazafen, tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumezopyrim, triflumuron, Bacillus thuringiensis delta-endotoxins, entomopathogenic bacteria, entomopathogenic viruses and entomopathogenic fungi.

9 . A composition for protecting an animal from an invertebrate parasitic pest comprising a parasiticidally effective amount of a compound of claim 1 and at least one carrier.

10 . A method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of claim 1 .

11 . The method of claim 10 wherein invertebrate pest comprises stink bugs from the family Pentatomidae.

12 . A treated seed comprising a compound of claim 1 in an amount of from about 0.0001 to 1% by weight of the seed before treatment.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Apr 17, 2026
From: FMC CORPORATION
To: CITIBANK, N.A.
Reel/Frame 075403/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2022
From: AHMAD, OMAR KHALED; BRIDDELL, TWYLA A.; CHAN, DOMINIC MING-TAK; CHEN, YUZHONG; HAMM, JASON CHARLES; KAR, MOUMITA; PAHUTSKI, THOMAS FRANCIS, JR.; STEVENSON, THOMAS MARTIN; XU, MING; SLACK, RACHEL
To: FMC CORPORATION
Reel/Frame 060915/0178 →
Continuity (2)
Provisional Application 62967838 · Jan 30, 2020
Related Publication 20230117403A1 · Apr 20, 2023
References Cited (6)
WO 2012087630 · 2012 [cited by applicant]
WO 2013158422 · 2013 [cited by applicant]
“Opportunities for Chiral Agrochemicals,” Williams, A., Pestic. Sci., 46, 3-9, 1995. [cited by examiner]
Patrick, G. L. “An Introduction to Medicinal Chemistry,” 6th Edition, Oxford, 2017, pp. 223-253, at 224-225, 230-231. [cited by examiner]
Kubinyi (3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity, vol. 2-3, Springer, 1998, see p. 243). [cited by examiner]
International Search Report of corresponding PCT International Application No. PCT/US2021/015643. [cited by applicant]